Roshni Kulkarni: The Hidden Cost of Underdiagnosed Bleeding Disorders
Roshni Kulkarni, Professor at Michigan State University, shared a post on LinkedIn:
”So glad that the financial impact of delayed diagnosis, under treatment is being recognized.
Thanks Sanjay Ahuja.”
Sanjay Ahuja, Chief Medical Officer at Indiana Hemophilia and Thrombosis Center, shared a post on LinkedIn։
”Women with bleeding disorders remain significantly underdiagnosed and undertreated.
Delays in diagnosis can extend for years, often resulting in repeated emergency visits, chronic anemia, lost productivity and avoidable procedures.
This is not simply a clinical issue. It is a systems and cost issue
Closing this gap for women is not only the right thing to do for patients – it is a high-value, cost-effective investment for any State.”
Stay updated with Hemostasis Today.
-
May 17, 2026, 15:03Mariam Swidan: IDA vs Thalassemia Trait-Disease Overview
-
May 17, 2026, 14:29Masoabi Sefojane: The Hidden Crisis in Haemophilia Care
-
May 17, 2026, 14:04What Happens When People with Hemophilia Need Orthopedic Surgery? – WFH
-
May 17, 2026, 13:51Soma Agrawal: Managing a Rare Anti-Jkᵃ Autoantibody in Thalassemia
-
May 17, 2026, 13:25Arun V. J.: There is a Black Market of Blood, And We Are Afraid To Admit It
-
May 17, 2026, 13:15Hilla Ben-Pazi: AMIT301 Receives Approval in Israel for Continuous Stroke Monitoring
-
May 17, 2026, 12:54Marilena Vrana: On Europe Day, We Celebrate the Promise to Stand Together
-
May 17, 2026, 12:41Zafer Tandogdu: Can TXA Redefine Bleeding Management in Urology
-
May 17, 2026, 12:19Amna Idrees: Reducing Surgical Blood Loss in Children Through Perioperative TXA